Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, April 22, 2015 12:01:48 PM
bullish
## source: finance.yahoo.com
Fri, 03 Apr 2015 11:00:00 GMT ~ Audi: Tesla model not for us
read full: http://finance.yahoo.com/video/ceo-tesla-model-not-us-110000491.html
*********************************************************
Thu, 02 Apr 2015 10:00:00 GMT ~ Jim Cramer's Top Takeaways: GoDaddy, FreshPet, TherapeuticsMD
read full: http://www.thestreet.com/story/13070448/1/jim-cramers-top-takeaways-godaddy-freshpet-therapeuticsmd.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Thu, 02 Apr 2015 00:22:00 GMT ~ Jim Cramer's 'Mad Money' Recap: Get Ready for a Rough Ride
read full: http://www.thestreet.com/story/13070480/1/jim-cramers-mad-money-recap-get-ready-for-a-rough-ride.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Wed, 01 Apr 2015 23:00:15 GMT ~ Cramer Remix: It's time to buy these oil stocks
read full: http://www.cnbc.com/id/102554913?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=102554913
*********************************************************
Wed, 01 Apr 2015 22:45:00 GMT ~ TherapeuticsMD CEO: Targeting women's health
read full: http://finance.yahoo.com/video/therapeuticsmd-ceo-targeting-womens-health-224500883.html
*********************************************************
$TXMD charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$TXMD company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/TXMD/company-info
Ticker: $TXMD
OTC Market Place: Not Available
CIK code: 0000025743
Company name: TherapeuticsMD, Inc.
Company website: http://www.therapeuticsmd.com
Incorporated In: NV, USA
Business Description: VitaMed is a specialty pharmaceutical company that has developed a patent-pending technology and business methodology to market both over-the-counter (\"OTC\") and prescription versions of nutritional supplements, drugs, medical foods and other medical products directly to consumers with the recommendation of their physician. VitaMed's business model creates unique value propositions for patients, physician/providers and insurance payors by eliminating much of the inefficiencies associated with the traditional sales, marketing and distribution models. VitaMed offers superior-quality products for a lower overall cost to patients and payors while increasing efficiencies for physicians. VitaMed's technology allows it to collect and analyze data from various sources to improve patient compliance and education, facilitate product development and provide immediate feedback on effectiveness of therapies. The result is increased efficiency and communication between the patient, physician/provider and insurance payor, ultimately creating improved outcomes for all. This combination of efficient distribution and technology provides measurable customer benefits differentiates VitaMed from existing competitors in the market.Less >>
$TXMD share structure
## source: otcmarkets.com
Market Value: $1,229,483,345 a/o Apr 21, 2015
Shares Outstanding: 171,715,551 a/o Mar 06, 2015
Float: 25,550,701 a/o Oct 15, 2012
Authorized Shares: 250,000,000 a/o Oct 23, 2011
Par Value: 0.1
$TXMD extra dd links
Company name: TherapeuticsMD, Inc.
Company website: http://www.therapeuticsmd.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=TXMD+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=TXMD+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=TXMD+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/TXMD/news - http://finance.yahoo.com/q/h?s=TXMD+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/TXMD/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/TXMD/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=TXMD+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/TXMD
DTCC (dtcc.com): http://search2.dtcc.com/?q=TherapeuticsMD%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=TherapeuticsMD%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=TherapeuticsMD%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.therapeuticsmd.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.therapeuticsmd.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.therapeuticsmd.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/TXMD
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000025743&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/TXMD/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/TXMD/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=TXMD&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=TXMD
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/TXMD/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=TXMD+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=TXMD+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=TXMD
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=TXMD
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=TXMD+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/TXMD/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=TXMD+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/TXMD.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=TXMD
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/TXMD/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/TXMD/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/TXMD
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/TXMD
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/TXMD:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=TXMD
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=TXMD
$TXMD DD Notes ~ http://www.ddnotesmaker.com/TXMD
Recent TXMD News
- TherapeuticsMD Announces Full Year 2023 Financial Results • Business Wire • 03/29/2024 08:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 09:51:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/06/2023 04:36:35 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/17/2023 02:28:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 02:27:23 PM
- TherapeuticsMD Announces Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 08:22:58 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 08:20:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 09:18:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 11:30:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 11:15:28 AM
- TherapeuticsMD Announces Second Quarter 2023 Financial Results • Business Wire • 08/14/2023 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2023 09:29:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2023 09:28:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2023 09:27:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/06/2023 08:38:59 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/30/2023 12:29:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:21:32 PM
- TherapeuticsMD Announces First Quarter 2023 Financial Results • Business Wire • 05/15/2023 08:05:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM